Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sonnet BioTherapeutics I...

    NASDAQ: SONN · Real-Time Price · USD
    3.53
    -0.23 (-6.12%)
    At close: Aug 15, 2025, 3:59 PM
    3.50
    -0.85%
    After-hours: Aug 15, 2025, 07:58 PM EDT

    Sonnet BioTherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Cash & Equivalents
    		 149.46K 2.27M 3.05M 27.62M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 509.15K 464.19K 113.28K n/a
    Receivables
    		 762.08K 786.57K 717.3K n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 1.21M 1.68M -717.3K n/a
    Total Current Assets
    		 2.12M 4.74M 5.41M 28.81M
    Property-Plant & Equipment
    		 143.94K 227.06K 302.81K 182.27K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 653.09K 691.25K 416.08K 182.27K
    Total Assets
    		 2.77M 5.43M 5.83M 28.99M
    Account Payables
    		 2.18M 2.2M 4.75M 3.78M
    Deferred Revenue
    		 n/a 18.63K 166.43K 516.37K
    Short-Term Debt
    		 n/a 73.05K 748.00 748.00
    Other Current Liabilities
    		 792.69K 1.07M 1.98M 1.32M
    Total Current Liabilities
    		 3.21M 5.52M 8.16M 6.7M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 46.57K 130.86K 203.91K 30.61K
    Total Liabilities
    		 3.26M 5.66M 8.37M 6.73M
    Total Debt
    		 130.86K 203.91K 255.99K 125.88K
    Common Stock
    		 65.00 175.00 554.00 6.03K
    Retained Earnings
    		 -117.68M -110.24M -91.41M -61.69M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 -485.74K -225.98K -2.54M 22.26M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist